Tiffany A. Traina
Memorial Sloan Kettering Cancer Center · 324 works · 13,174 citations · h-index 43
Top works
- OncoKB: A Precision Oncology Knowledge Base
- Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer
- PIK3CA Mutation Associates with Improved Outcome in Breast Cancer
- The Genomic Landscape of Endocrine-Resistant Advanced Breast Cancers
- Phase II Trial of Bicalutamide in Patients with Androgen Receptor–Positive, Estrogen Receptor–Negative Metastatic Breast Cancer
- TBCRC009: A Multicenter Phase II Clinical Trial of Platinum Monotherapy With Biomarker Assessment in Metastatic Triple-Negative Breast Cancer
- Androgen Receptor Levels and Association with PIK3CA Mutations and Prognosis in Breast Cancer
- Male breast cancer: a disease distinct from female breast cancer
- Enzalutamide for the Treatment of Androgen Receptor–Expressing Triple-Negative Breast Cancer
- Palbociclib with adjuvant endocrine therapy in early breast cancer (PALLAS): interim analysis of a multicentre, open-label, randomised, phase 3 study
- Triple-Negative Breast Cancer: Adjuvant Therapeutic Options
- Nasal Septum Perforation in a Bevacizumab-Treated Patient with Metastatic Breast Cancer
- Triple-Negative Breast Cancer
- Breast-Conserving Therapy Achieves Locoregional Outcomes Comparable to Mastectomy in Women with T1-2N0 Triple-Negative Breast Cancer
- Results from a phase 2 study of enzalutamide (ENZA), an androgen receptor (AR) inhibitor, in advanced AR+ triple-negative breast cancer (TNBC).
- Gonadotropin-Releasing Hormone Agonists for Ovarian Function Preservation in Premenopausal Women Undergoing Chemotherapy for Early-Stage Breast Cancer
- Cognitive Impairment in Older Patients With Breast Cancer Before Systemic Therapy: Is There an Interaction Between Cancer and Comorbidity?
- Palbociclib: an evidence-based review of its potential in the treatment of breast cancer
- Favorable prognosis in patients with T1a/T1bN0 triple‐negative breast cancers treated with multimodality therapy
- American Society of Clinical Oncology Road to Recovery Report: Learning From the COVID-19 Experience to Improve Clinical Research and Cancer Care